Scholar Rock Holding Corporation (SRRK)

[retireat40]

Wow. Now a $7 stock

[georgie18]

SRRK...$34.75...on the 100ma break...:party:
[11:57 AM]
georgie18 — 10/29/2021
SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside as the Psar flipped Bullish...

Pincher Squeeze in play here...as the MACD Crosses Positive...Looking for a $40 Break/Hold...imo...we shall see...:party:

[georgie18]

SRRK...$28.45...Lets see if we can Break/Hold the Upper Band today...as the Bollie Squeeze sets up here...imo...We shall see...:party:
[4:32 AM]
georgie18 — 10/29/2021
SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside as the Psar flipped Bullish...

Pincher Squeeze in play here...as the MACD Crosses Positive...Looking for a $40 Break/Hold...imo...we shall see...:party:

[georgie18]

SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside as the Psar flipped Bullish...

Pincher Squeeze in play here...as the MACD Crosses Positive...Looking for a $40 Break/Hold...imo...we shall see...

Played this in the spring for nice profits...Back in again on this Pattern...

Chart... https://schrts.co/HtbEtPcc ...

[georgie18]

SRRK...$31.62...on the 50ma Break to the Upside...:party:
[6:26 AM]
georgie18 — 05/24/2021
SRRK...$28.75...Took a starter on the Bullish Harami today...:party:

[georgie18]

SRRK...$29.69...in the P/M...https://finance.yahoo.com/news/scholar-rock-presents-topaz-phase-113000823.html ...:party:

[stockguard]

We`ll be back to higher highs soon.

[georgie18]

SRRK...$28.75...Took a starter on the Bullish Harami today...CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for apitegromab, a selective inhibitor of myostatin activation, for the treatment of patients with Spinal Muscular Atrophy (SMA). Fast Track designation is intended to facilitate the development and expedite the review of drugs to treat serious conditions and get new drugs to patients earlier. Through Fast Track, Scholar Rock is eligible to submit a rolling Biologic License Application (BLA) for apitegromab if relevant criteria are met...

[stockguard]

Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy
https://www.businesswire.com/news/home/20210524005771/en/

[stockguard]

Scholar Rock weakness overdone after TOPAZ results, says JPMorgan
JPMorgan analyst Anupam Rama noted that Scholar Rock shares are down about 15%, which Rama views as "overdone," after the company announced update 12-month results from the phase 2 TOPAZ study in the treatment of Type 2/3 Spinal Muscular Atrophy. The 12-month data showed relatively consistent functional benefit compared to six-month interim data reported in October, noted Rama, who added that "there were no major concerns" on the safety front. The analyst, who sees the "totality of data as a probability of success increase lever," reiterates an Overweight rating on Scholar Rock shares.

[georgie18]

SRRK...$48.08...Back in on the Bullish Engulfing Candle on the Overbought Retrace...Psar will flip to a Bullish Buy Position this week...

Break/Hold $52 with no topside resistance and we make a run at $75/$100 range on this Blue Skies Chart...imo...we shall see...

Chart..https://schrts.co/wGhsGXPZ

georgie18 Wednesday, 10/28/20 06:38:13 AM
Re: None 0
Post #
3
of 21
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...

[georgie18]

SRRK...$46.91...Looking for the Upper Bollie breakout...on the Pole N Flag Breakout...imo...we shall see...

georgie18 Tuesday, 11/24/20 07:16:17 AM
Re: georgie18 post# 3 0
Post #
19
of 20
SRRK...$41.40...Bullish Pole N Flag Breakout setting up here as the Bollies start to Squeeze here...Looking for $75/$100 move...imo...we shall see...

Chart... http://schrts.co/rzYtEpQt

georgie18 Wednesday, 10/28/20 06:38:13 AM
Re: None 0
Post #
3
of 19
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...

[georgie18]

SRRK...$46.91...on the Upper Bollie Break...

[georgie18]

SRRK...$41.40...Bullish Pole N Flag Breakout setting up here as the Bollies start to Squeeze here...Looking for $75/$100 move...imo...we shall see...

Chart... http://schrts.co/rzYtEpQt

georgie18 Wednesday, 10/28/20 06:38:13 AM
Re: None 0
Post #
3
of 19
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...

[JohnQQ]

https://finance.yahoo.com/m/9fae2849-74b9-3d45-9293-6540a970693d/2-top-biotech-stocks-from-the.html

[JohnQQ]

New Seeking Alpha Article

[JohnQQ]

SOME SHORTS DID NOT CLOSE HAHA !

https://seekingalpha.com/article/4384830-scholar-rock-is-phase-2-1-billion-is-too-expensive

[Pedro2004]

I think the run is over.
They just did a Private Placement at $39.00
Let's see what happens in a few months.

[TheFinalCD]

$41's wow CONGRATS to anyone making money here


SRRk

[Pedro2004]

Thanks. This company woke up very quickly.

[ClayTrader]

* * $SRRK Video Chart 10-29-2020 * *

Link to Video - click here to watch the technical chart video

[georgie18]

SRRK...$43.43...CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the pricing of an underwritten public offering of 2,948,718 shares of its common stock at a public offering price of $39.00 per share...

No position at the moment after the $11 range alert ran to $45 range...

[ClayTrader]

* * $SRRK Video Chart 10-28-2020 * *

Link to Video - click here to watch the technical chart video

[easymoney]

Sold before eod lol well traded like 10 times today and yesterday

[PAC]

Book runners pumping to short shares to absorb the offering at a lower price. $150m worth will be a lot of shares for them to accumulate short. that's why the run up and squeeze.

Seems like co. desperate for money bc the results were interim of phase 2. maybe get a pricing below $30

[TheFinalCD]

45.30 CONGRATS!!!


SRRK

[TheFinalCD]

SRRK $40 BROKE!!


42.11 HOD

[Pedro2004]

Let's see if this breaks $40.00 today.

[Pedro2004]

I agree. I was watching this since yesterday, In at 23, out at 24.50.

[georgie18]

SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...

[Jornwell]

Dilution always kills at this pps, look at DRYS I would stay away for now unless TA shows uptick in buying activity

[ASPD_Capital]

Spinal Muscular Atrophy (SMA) affects between 1 in 6,000 to 1 in 10,000 depending on type. $SRRK tested SRK-015 on 58 people and they improved a little. Still a ways to go for a marginally rare disease. At the same time, the company announced intent to issue $150 million worth of new shares at an undisclosed price with a $22.5 million option. Please post your thoughts on whether this price action continues or if dilution and loss of interest tanks it. I'm definitely torn. LOL